Use of NeuroSAFE during prostatectomy nearly doubled the number of patients who had no or mild erectile dysfunction ...

A prostate cancer patient said he was "delighted" to be back in his own bed the same day as undergoing major robotic surgery.

Use of NeuroSAFE to guide nerve-sparing surgery results in improvement in erectile function at 12 months and urinary continence at 3 months.

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

Radical prostatectomy: surgical removal of the prostate ... Among 344 patients who underwent surgery for prostate cancer — 173 in the NeuroSAFE group and 171 in the standard RARP group at a median ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE ... robot-assisted radical ...

Should a person require surgery, a urologist will carry out the procedure. This is a surgeon who specializes in the treatment of urinary system disorders. They may perform a radical prostatectomy ...

Sexual activity and interest declined gradually during 5 years in the radiotherapy group; in the surgery group ... quantitate adverse outcomes after radical prostatectomy and radiotherapy for ...